Plus   Neg

Zogenix Inc. (ZGNX) Has Broken Out To A New High On Study Results

Zogenix Inc. (ZGNX) announced Thursday morning that its second Phase 3 study of ZX008 met the primary endpoint and all key secondary endpoints.

Zogenix gapped open sharply higher this morning and is now up 9 points at $55.30 on above average volume. The stock has jumped to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT